Study guide
5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
Certified Burn Registered Nurse CBRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Foundations of Burn Care
1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones
2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response
2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology
3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria
3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics
4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)
4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy
5 Chapter 5: Airway Management & Inhalation Injury Management
5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
6 Chapter 6: Acute Multisystem Assessment & Critical Care Management
6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
7 Chapter 7: Hypermetabolism & Nutritional Support
7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation
8 Chapter 8: Pain Management in Burn Care
8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction
9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus
9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients
10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings
10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances
11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure
11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management
12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy
12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion
13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries
13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy
14 Chapter 14: Special Burn Populations & Cutaneous Syndromes
14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries
15 Chapter 15: Rehabilitation, Scar Management & Reconstruction
15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management
16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage
16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response
5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
Key Takeaways Explain This Topic AI
Carbon monoxide (CO) binds hemoglobin with an affinity 200–250 times greater than oxygen, forming carboxyhemoglobin (COHb), shifting the oxyhemoglobin dissociation curve to the left, and inhibiting mitochondrial cytochrome c oxidase.
Standard dual-wavelength pulse oximetry (SpO2) cannot differentiate oxyhemoglobin from carboxyhemoglobin, yielding falsely normal readings; definitive diagnosis requires multi-wavelength arterial or venous blood co-oximetry.
Immediate administration of 100% high-flow normobaric oxygen reduces the half-life of COHb from 240–360 minutes on room air down to 40–80 minutes; hyperbaric oxygen (HBO) further shortens it to 20–30 minutes and is indicated for COHb > 25%, syncope, neurological deficits, or pregnancy with COHb > 15%.
Hydrogen cyanide (HCN) from synthetic polymer pyrolysis binds ferric iron (Fe3+) in mitochondrial cytochrome a3 oxidase, arresting the electron transport chain and producing catastrophic histotoxic hypoxia with profound, refractory lactic acidosis (> 8–10 mmol/L).
Hydroxocobalamin (Cyanokit, 5.0 g IV over 15 min) is the first-line antidote for cyanide poisoning, converting cyanide to non-toxic cyanocobalamin (Vitamin B12); it causes transient chromaturia (dark red urine), skin erythema, and temporary interference with colorimetric lab tests and dialysis leak detectors.
Last updated: August 2026
5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
Core Knowledge: Systemic asphyxiants are responsible for the vast majority of immediate fatalities in enclosed-space structure fires. The two primary toxic inhalants— Carbon Monoxide (CO) and Hydrogen Cyanide (HCN) —act synergistically to paralyze tissue oxygen delivery and cellular energy production. Carbon monoxide displaces oxygen from hemoglobin and shifts the dissociation curve to prevent oxygen unloading. Simultaneously, cyanide arrests mitochondrial oxidative phosphorylation, causing profound cellular histotoxic hypoxia. Recognizing the classic diagnostic pitfalls (such as falsely normal pulse oximetry) and initiating rapid antidotal therapy with 100% oxygen and hydroxocobalamin (Cyanokit) are vital competencies for the burn nurse.
Carbon Monoxide (CO) Poisoning: Molecular Pathophysiology
Carbon monoxide is a colorless, odorless, non-irritating gas produced by the incomplete combustion of carbon-containing organic materials. ┌────────────────────────────────────────────────────────────────────────┐
- │ CARBON MONOXIDE (CO) PATHOLOGY │
- │ │
- │ Affinity for Hemoglobin 200–250x Greater than Oxygen │
- │ │ │
- │ ▼ │
- │ Formation of Carboxyhemoglobin (COHb) │
- │ │ │
- │ ┌──────────────────────┴──────────────────────┐ │
- │ ▼ ▼ │
- │ Severe Leftward Shift of Oxyhemoglobin Inhibition of Mitochondrial │
- │ Dissociation Curve (Haldane Effect) Cytochrome c Oxidase & │
- │ (Failure of Peripheral Oxygen Release) Myoglobin Dysfunction │
- │ │ │ │
- │ └──────────────────────┬──────────────────────┘ │
- │ ▼ │
- │ PROFOUND TISSUE HYPOXIA & METABOLIC ACIDOSIS │
- └────────────────────────────────────────────────────────────────────────┘
- 1. High Hemoglobin Affinity and the Leftward Curve Shift
200–250x Affinity: Carbon monoxide binds to the iron ( F e 2 + Fe^{2+} F e 2 + ) binding sites of hemoglobin with an affinity 200 to 250 times higher than that of oxygen, forming carboxyhemoglobin (COHb) .
Allosteric Alteration: When CO binds to one of hemoglobin's four heme sites, it induces an allosteric conformational change that increases the oxygen affinity of the remaining three heme sites. This shifts the oxyhemoglobin dissociation curve sharply to the left (the Haldane effect).
The Dual Insult: CO not only reduces the total oxygen-carrying capacity of the blood by occupying binding sites, but it also locks the remaining oxygen onto the hemoglobin molecule, preventing its release at the capillary-tissue interface.
2. Myoglobin Binding and Mitochondrial Cytochrome Inhibition
Myoglobin Inactivation: CO binds to intracellular cardiac and skeletal myoglobin with high affinity, impairing oxygen storage, depressing myocardial contractility, and precipitating acute dysrhythmias and myocardial ischemia.
Cytochrome c Oxidase Inhibition: Intracellular CO directly binds to mitochondrial cytochrome c oxidase (Complex IV of the electron transport chain), halting cellular ATP synthesis and triggering lipid peroxidation, neuronal damage, and delayed neuropsychiatric sequelae.
Diagnostic Imperatives for Carbon Monoxide: The Pulse Oximetry Fallacy
One of the most dangerous clinical pitfalls in emergency burn care is relying on standard pulse oximetry. ┌──────────────────────────────────────────────┐
- │ DIAGNOSTIC PITFALL: PULSE OXIMETRY │
- └──────────────────────┬───────────────────────┘
- │
- ┌────────────────────────┴────────────────────────┐
- ▼ ▼
- ┌───────────────────────────────┐ ┌────────────────────────────────┐
- │ STANDARD 2-WAVE PULSE OX (SpO2│ │ BLOOD GAS CO-OXIMETRY (COHb %) │
- │ • Measures 660 nm & 940 nm │ │ • Multi-wavelength light absorp│
- │ • CANNOT distinguish HbO2 │ │ • Accurately separates HbO2, │
- │ from COHb │ │ COHb, MetHb, and DeoxyHb │
- │ • FALSELY NORMAL (99-100%) │ │ • TRUE DIAGNOSTIC GOLD STANDARD│
- └───────────────────────────────┘ └────────────────────────────────┘
- Why SpO2 is Falsely Normal
Standard transcutaneous pulse oximeters emit two wavelengths of light: 660 nm (red) and 940 nm (infrared) . Oxyhemoglobin ( H b O 2 HbO_2 H b O 2 ) and carboxyhemoglobin ( C O H b COHb CO H b ) have virtually identical light absorption characteristics at 660 nm. The standard pulse oximeter misinterprets COHb as pure oxyhemoglobin, displaying a falsely reassuring SpO2 of 99% to 100% , even in a comatose patient with a lethal COHb level of 60%.
The Gold Standard: Co-Oximetry
Definitive diagnosis requires a blood gas (arterial or venous) analyzed via a multi-wavelength co-oximeter (or a specialized multi-wavelength noninvasive pulse co-oximeter, such as a Masimo Rad-57). Co-oximeters measure light absorption across multiple wavelengths, mathematically isolating oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, and methemoglobin.
COHb Levels and Clinical Correlation
- COHb Level (%) Patient Status / Typical Presentation Primary Clinical Manifestations
- < 2–3% Normal Baseline (Non-smokers) None; physiological baseline
- 5–9% Heavy Cigarette Smokers / Urban Transit Asymptomatic or mild baseline tolerance
- 10–20% Mild Intoxication Frontal headache, mild dyspnea, nausea, fatigue, flushing
20–40% Moderate Intoxication Throbbing headache, severe dizziness, confusion, lethargy, visual disturbances, tachycardia, tachypnea, ataxia
40–60% Severe Toxicity Syncope, generalized seizures, obtundation, coma, ECG changes (ST depression/elevation), ventricular arrhythmias
> 60% Critical / Fatal Cardiorespiratory arrest, refractory shock, brain death
Note
The "Cherry-Red Skin" Myth: Textbooks historically described "cherry-red lips and skin" as the hallmark of CO poisoning. In clinical practice, cherry-red skin is exceptionally rare in living patients and is almost exclusively a post-mortem finding. Never exclude CO toxicity due to the absence of red skin.
Pharmacokinetics of Oxygen Therapy and Hyperbaric Oxygen (HBO)
Oxygen is the direct antidote for carbon monoxide poisoning, functioning by competitive mass action to displace CO from hemoglobin binding sites. ┌──────────────────────────────────────────┐
- │ ELIMINATION HALF-LIFE OF COHb (t½) │
- └────────────────────┬─────────────────────┘
- │
- ┌────────────────────────────┼────────────────────────────┐
- ▼ ▼ ▼
- ┌──────────────────┐ ┌──────────────────┐ ┌──────────────────┐
- │ ROOM AIR (21% O2)│ │ 100% NORMOBARIC │ │ HYPERBARIC (HBO) │
- │ │ │ (NRB Mask / ETT) │ │ (2.5 - 3.0 ATA) │
- │ t½ = 240–360 min │ │ t½ = 40–80 min │ │ t½ = 20–30 min │
- │ (4 to 6 hours) │ │ (~1 hour) │ │ (<30 minutes) │
- └──────────────────┘ └──────────────────┘ └──────────────────┘
- Initial Management
Every patient with suspected smoke inhalation must immediately receive 100% high-flow normobaric oxygen via a tight-fitting non-rebreather mask (or mechanical ventilator) until the COHb level drops below 3% to 5% and all neurological symptoms have fully resolved.
Indications for Hyperbaric Oxygen (HBO) Therapy
Hyperbaric oxygen therapy delivers 100% oxygen at 2.5 to 3.0 atmospheres absolute (ATA) inside a pressurized monoplace or multiplace chamber. HBO accelerates CO clearance, reverses cytochrome oxidase inhibition, and significantly reduces the incidence of Delayed Neurological Sequelae (DNS) .
Primary Indications for HBO Referral:
COHb Level > 25% in any adult patient.
Pregnancy with COHb Level > 15%: Fetal hemoglobin ( H b F HbF H b F ) binds CO with even higher affinity than maternal hemoglobin, and the fetus has lower baseline oxygen tension, placing it at severe risk for fetal death or teratogenesis.
History of Loss of Consciousness (Syncope): Any transient or prolonged blackout.
Neurological Abnormalities: Confusion, altered mental status, focal deficits, or seizures.
Severe Metabolic / Lactic Acidosis: Marked base deficit or profound acidemia ( p H < 7.25 pH < 7.25 p H < 7.25 ).
Evidence of Myocardial Ischemia: Ischemic ECG changes, acute arrhythmias, or elevated cardiac troponin.
Hydrogen Cyanide (HCN) Poisoning: Cellular Histotoxic Hypoxia
Hydrogen cyanide gas is generated during the pyrolysis (thermal breakdown) of synthetic nitrogen-containing household materials, including polyurethane foams (furniture cushions), plastics, nylon, acrylics, melamine, and synthetic carpets . ┌────────────────────────────────────────────────────────────────────────┐
- │ HYDROGEN CYANIDE (HCN) PATHOLOGY │
- │ │
- │ Pyrolysis of Synthetic Household Materials (Polyurethanes, Plastics) │
- │ │ │
- │ ▼ │
- │ Rapid Alveolar Absorption into Systemic Bloodstream │
- │ │ │
- │ ▼ │
- │ Cyanide Binds Ferric Iron (Fe3+) in Mitochondrial Cytochrome a3 │
- │ (Complex IV of Electron Transport Chain) │
- │ │ │
- │ ▼ │
- │ COMPLETE ARREST OF AEROBIC ATP SYNTHESIS (HISTOTOXIC HYPOXIA) │
- │ │ │
- │ ┌──────────────────────┴──────────────────────┐ │
- │ ▼ ▼ │
- │ Massive Anaerobic Glycolysis Tissues Cannot Extract O2 │
- │ (Refractory Lactic Acidosis >8-10 mmol/L) (Elevated SvO2 >85-90%) │
- └────────────────────────────────────────────────────────────────────────┘
- Pathophysiological Mechanism
Inhibition of Cytochrome a3 Oxidase: Cyanide enters cells and binds with high affinity to the ferric iron ( F e 3 + Fe^{3+} F e 3 + ) ion within the heme moiety of mitochondrial cytochrome a 3 a_3 a 3 oxidase (Complex IV). This arrests the final step of the electron transport chain, completely preventing the transfer of electrons to oxygen.
Histotoxic Hypoxia: Cellular respiration ceases. Even though arterial blood is fully saturated with oxygen ( PaO 2 \text{PaO}_2 PaO 2 is normal), cells cannot utilize oxygen to generate ATP. The body shifts exclusively to anaerobic glycolysis, generating massive quantities of lactic acid.
Diagnostic Triad for Cyanide Poisoning in Smoke Inhalation
Cyanide blood levels take hours or days to return from reference laboratories. Clinicians must identify cyanide toxicity using a classic bedside triad:
History of Enclosed-Space Smoke Exposure with soot deposits or facial burns.
Profound, Refractory Lactic Acidosis: Serum lactate > 8.0 to 10.0 mmol/L in a burn patient who has not suffered catastrophic hemorrhagic shock.
Elevated Central Venous Oxygen Saturation (SvO2 > 85–90%): Because peripheral cells are poisoned and unable to extract oxygen from circulating blood, venous blood returns to the heart paradoxically hyper-oxygenated, narrowing the arteriovenous oxygen difference ( A − V DO 2 A-V\text{DO}_2 A − V DO 2 ).
Antidote Administration: Hydroxocobalamin (Cyanokit)
Hydroxocobalamin is the first-line, evidence-based antidote of choice for cyanide poisoning in burn and smoke inhalation victims. ┌──────────────────────────────────────────┐
- │ HYDROXOCOBALAMIN (CYANOKIT) ACTION │
- └────────────────────┬─────────────────────┘
- │
- ▼
- ┌────────────────────────────────────────────────────────────┐
- │ Hydroxocobalamin (Contains Cobalt Center with -OH Group) │
- │ + │
- │ Cyanide Ion (CN⁻ from Cytochrome a3) │
- │ │ │
- │ ▼ │
- │ Cyanocobalamin (Non-Toxic Vitamin B12) │
- │ │ │
- │ ▼ │
- │ Excreted Safely in Urine (Causes Harmless Dark Red Urine) │
- └────────────────────────────────────────────────────────────┘
- Dosing and Administration Protocol
First-Line Dose: 5.0 grams IV infused over 15 minutes (in two separate 2.5 g vials reconstituted with 100 mL of 0.9% Normal Saline each).
Second Dose: A second dose of 5.0 grams IV (total 10.0 g) may be infused over 15 minutes to 2 hours depending on the severity of intoxication and clinical response (persistent lactic acidosis, hemodynamic collapse).
Pediatric Dosing: 70 mg/kg 70 \text{ mg/kg} 70 mg/kg IV (maximum 5.0 g).
Why Hydroxocobalamin is Preferred Over Traditional Nitrite Kits
Traditional cyanide antidote kits contained sodium nitrite and amyl nitrite , which induce methemoglobinemia ( F e 2 + → F e 3 + Fe^{2+} \rightarrow Fe^{3+} F e 2 + → F e 3 + ) so that methemoglobin scavenges cyanide. In smoke inhalation victims who often have concurrent carbon monoxide toxicity , creating methemoglobin further degrades oxygen-carrying capacity, precipitating fatal tissue hypoxia. Hydroxocobalamin does not induce methemoglobinemia and has no adverse effect on oxygen-carrying capacity.
Clinical Pearls, Side Effects, and Laboratory Interferences
Feature Clinical Presentation & Nursing Action
Chromaturia (Red Urine) Urine turns a distinct dark, reddish-wine color immediately following infusion, persisting for 2 to 7 days . Reassure the patient and family; this is harmless excretion of cyanocobalamin and not hematuria or myoglobinuria.
Erythema (Red Skin) Transient reddish skin and mucous membrane discoloration lasting up to 48 hours.
Transient Hypertension Scavenging of endogenous endothelial nitric oxide by hydroxocobalamin produces a transient, self-limiting rise in blood pressure (often beneficial in hypotensive cyanide victims).
Colorimetric Lab Interference The intense red chromophore of hydroxocobalamin interferes with colorimetric spectrophotometric assays : falsely elevates COHb on co-oximetry, falsely alters creatinine, bilirubin, AST, ALT, and coagulation tests (PT/INR, aPTT). Nursing Action: Always draw baseline blood gas, lactate, and chemistry tubes before infusing Cyanokit whenever possible without delaying care.
Dialysis Blood Leak Alarms Red-colored plasma triggers false-positive "blood leak" optical alarms on Continuous Renal Replacement Therapy (CRRT) or hemodialysis machines. Inform the nephrology team.